oncology APISintaho Pharmaceutical Ltd was established in the year of 2016 and headquartered in Chongqing China, with a grand vison of being the most trusted partner to pharmaceutical companies worldwide. We have a clear focus on developing and manufacturing highly potent and cytotoxic Active Pharmaceutical Ingredients (APIs) and CDMO services.
Tirbanibulin is a potent topical kinase inhibitor developed for dermatological treatments. Its core synthesis involves specific chemical pathways to ensure high purity. The compound is defined by the molecular formula C21H25N7O4S and carries CAS No. 1968077-88-8.
Strictly for topical use only; avoid contact with eyes and mucous membranes. Store in a cool, dry place protected from light at controlled room temperature (20°C to 25°C). Do not exceed prescribed duration to prevent severe local reactions.